This inventor holds 2 USPTO granted patents. Top assignees: Riom Laboratories C.e.r.m., Riom Laboratories C.e.r.m. 'Rl-c.e.r.m.' S.a.. Active years: 1986-1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3 
1 out of 1 Years Active: 1986-1989
Title: The Innovative Mind of Yvon Bernet
Introduction
Yvon Bernet, an accomplished inventor based in Jussac, France, has made significant contributions to the field of pharmaceuticals. With a total of two patents to his name, Bernet's work primarily focuses on developing compounds with anti-arrhythmic and antispasmodic properties. His innovative spirit and dedication to research have firmly established him in the realm of pharmaceutical advancements.
Latest Patents
Among Yvon Bernet's latest patents are advancements in 1,3-propanediamine derivatives, including a specifically designed antiauhythmic pharmaceutical compound known for its anti-arrhythmic properties. This compound, designated as N,N-dimethyl-N'-benzoyl-N'-(2,3-dihydrobenzofuran-2-ylmethyl)1,3-propanediamine, proves to be a remarkable achievement in improving heart health. Furthermore, his research led to the development of hexahydrodibenzodioxane compounds, which are designed as antispasmodic agents. These compounds, characterized by specific structural formulas, showcase a range of functionalities that hold promise for effective pharmaceutical compositions.
Career Highlights
Yvon Bernet has been associated with notable organizations such as Riom Laboratories. His tenure at such esteemed institutions has enabled him to work at the forefront of pharmaceutical innovation, contributing significantly to the development of new drugs and treatments. His focus on synthesizing compounds that address critical medical issues highlights his impact on the health sector.
Collaborations
Throughout his career, Yvon Bernet has had the opportunity to collaborate with esteemed colleagues, including Michel Combourieu and Nadine Simbille. These collaborations have fostered a productive environment for exchange of ideas, leading to enhanced innovation and research outcomes. The synergy among these professionals has undoubtedly played a vital role in Bernet's successes.
Conclusion
Yvon Bernet's work exemplifies the essence of innovation in pharmaceuticals. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes. As he continues to explore new avenues in research, Bernet's contributions will surely leave a lasting mark in the field of medicine, paving the way for future breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile